The Effect of Time-Restricted Eating on Metabolic Risk Factors for Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease in Overweight and Obese Adults: A Systematic Review and Meta-Analysis
Park J, Kim MS, Boo YK
Nutrition reviews · 1 cita
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Metaanálisis (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2025-09-17 · Nutr Rev · vol. 84 · número 4 · págs. 667–683
- Editorial
- Oxford University Press
- Citado
- 2 citas · más que el 54% de estudios similares · 0.4× el promedio de su campo
- Referencias
- 87 trabajos
- Acceso
- De pago
- Áreas de investigación
- Dietary Effects on Health · Circadian rhythm and melatonin · Enhanced Recovery After Surgery
- Palabras clave
- Disease, Fatty liver, Overweight, Obesity, Metabolic syndrome, Risk factor
- MeSH
- humans, cardiovascular diseases, insulin resistance, obesity, fasting, risk factors, adult, female, male, overweight, randomized controlled trials as topic, non-alcoholic fatty liver disease, cardiometabolic risk factors
3 autores
- Jooho Park🇰🇷Dankook University
- Min Soo Kim🇰🇷Dankook University
- Yoo-Kyung Boo🇰🇷 · autor de correspondenciaDankook University
Resumen
El texto original del estudio, en el idioma en que se publicó.
Context
Time-restricted eating (TRE) is an effective dietary strategy for reducing overweight, obesity, and related complications, offering flexibility to fit individual preferences. However, its effects vary depending on individual conditions, and to date insufficient research in human studies has been conducted to support its recommendation as a healthy eating approach.
Objective
This study took the form of a systematic review and meta-analysis to evaluate the effects of TRE on overweight and obesity in adults and on metabolic risk factors, specifically cardiovascular diseases (CVDs) and non-alcoholic fatty liver disease (NAFLD), considering fasting window, a common intervention, intake management, and intervention duration.
Data sources
A literature search was conducted on October 10, 2024, using the Ovid MEDLINE, Cochrane CENTRAL, Embase, Web of Science, Scopus, and CINAHL databases.
Data extraction
The study followed the PRISMA checklist and included 28 randomized controlled trials (RCTs) with 1648 participants. The outcomes analyzed included weight, waist circumference, fat mass, plasma lipids, Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), fasting glucose, and fasting insulin.
Data analysis
The meta-analysis showed large effect sizes (ESs) for weight (ES: -1.40, 95% CI: -2.33 to -0.48) and waist circumference (ES: -0.75, 95% CI: -0.93 to -0.56), and a moderate ES for fat mass (ES: -0.61, 95% CI: -0.98 to -0.24). A small effect was found for HOMA-IR (ES: -0.29, 95% CI: -0.48 to -0.10). While there was heterogeneity for weight and fat mass, the sensitivity analyses were robust. In contrast, the effects on plasma lipids, fasting glucose, and fasting insulin were inconclusive.
Conclusions
TRE may ameliorate metabolic risk factors in adults with overweight and obesity, offering a flexible approach adaptable to individual lifestyles. However, reductions in weight and fat mass may depend on the individual conditions, and the medications taken by individuals may influence the outcomes. Furthermore, interventional studies on TRE remain insufficient, necessitating further experimental research, systematic reviews, and meta-analyses to better understand the effects of TRE.
Systematic review registration
PROSPERO registration No. [CRD42024556381].
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.